<DOC>
	<DOCNO>NCT02403375</DOCNO>
	<brief_summary>This study compare metabolic control , treatment satisfaction , quality life continuous subcutaneous insulin infusion ( CSII ) therapy new insulin pump system multiple daily injection ( MDI ) therapy . Furthermore , study add clinical data originate clinical investigation special population , i.e . child adolescent age 2 - 17 year , exist clinical data ACCU-CHEK Insight insulin pump .</brief_summary>
	<brief_title>Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Reach HbA1c Targets Children Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Children adolescent least 24 month age , 17 year age screening Diagnosed type 1 diabetes Diagnosis type 1 diabetes establish &gt; 6 month study start &gt; 5 year age Indication insulin pump therapy accord local guideline Subject 's recent HbA1c equal 7.0 % ( 53.0 mmol/mol ) measure last assessment screen within past 2 month prior Baseline Visit study Willingness use automate bolus advice obtain AccuChek Insight diabetes therapy system study Willingness ability participate comply study procedure Disease condition opinion investigator likely affect compliance ability complete study Not willing able start insulin pump therapy Not willing selfmeasure blood glucose least four time daily Significantly impaired awareness hypoglycemia More one hospitalization severe hypoglycemia last 12 month History recurrent ketoacidosis intensive insulin therapy Known strong plaster incompatibility and/or allergy Unstable chronic disease diabetes ( e.g . impaired hepatic function , impaired renal function , impaired cardiac function , uncontrolled vascular complication ) condition interfere study procedure , per Investigator´s discretion . If antihypertensive , thyroid , antidepressant lipidlowering medication , lack stability medication past 2 month prior Baseline Visit study Chronic use steroid adrenal suppressive dos , immunomodulatory medication chemotherapy Prescription medication insulin interfere diabetes management Acute illness abnormality ( e.g . impaired vision , impaired motor function , acute pain ) time screen interfere study procedure , affect compliance , ability complete study per Investigator´s discretion Either pregnant breastfeed Drug dependency Dependency sponsor Investigator ( e.g . coworker family member )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>